| Home > Publications Database > Real-space navigation testing differentiates between amyloid-positive and -negative aMCI |
| Journal Article | DZNE-2020-01257 |
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
2020
Ovid
[S.l.]
This record in other databases:
Please use a persistent id in citations: doi:10.1212/WNL.0000000000008758
Keyword(s): Aged (MeSH) ; Amnesia: cerebrospinal fluid (MeSH) ; Amnesia: complications (MeSH) ; Amnesia: physiopathology (MeSH) ; Amyloid: cerebrospinal fluid (MeSH) ; Case-Control Studies (MeSH) ; Cerebral Cortex: physiopathology (MeSH) ; Cognitive Dysfunction: cerebrospinal fluid (MeSH) ; Cognitive Dysfunction: complications (MeSH) ; Cognitive Dysfunction: physiopathology (MeSH) ; Female (MeSH) ; Fluorodeoxyglucose F18: metabolism (MeSH) ; Functional Neuroimaging (MeSH) ; Hippocampus: physiopathology (MeSH) ; Humans (MeSH) ; Male (MeSH) ; Middle Aged (MeSH) ; Neuropsychological Tests (MeSH) ; Positron-Emission Tomography (MeSH) ; Spatial Navigation: physiology (MeSH) ; Visual Perception: physiology (MeSH)
|
The record appears in these collections: |